keyword
https://read.qxmd.com/read/38621952/-economic-evaluation-of-annao-pills-combined-with-antihypertensive-drugs-in-treatment-of-primary-hypertension-a-study-based-on-decision-tree-model
#1
JOURNAL ARTICLE
Zi-Jia Chen, Xin Cui, Sheng Han, Meng Qiao, Chang-Kuan Fu, Zhi-Fei Wang, Yan-Ming Xie
The purpose of this study was to evaluate the economics of Annao Pills combined with antihypertensive drugs in the treatment of primary hypertension in the Chinese medical setting. TreeAge pro 2018 was used for cost-effect analysis and sensitivity analysis of the two treatment regimens. The intervention time of the simulation model was 2 weeks. The cost parameters were derived from Yaozhi.com, and the effect parameters were based on Meta-analysis of randomized controlled trial(RCT) involving Annao Pills. The experimental group was treated with Annao Pills combined with anti-hypertensive drugs(nifedipine controlled-release tablets + losartan potassium tablets), and the control group was treated with anti-hypertensive drugs(nifedipine controlled-release tablets + losartan potassium tablets)...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38621548/cost-effectiveness-analysis-of-fluticasone-furoate-umeclidinium-bromide-vilanterol-and-umeclidinium-bromide-vilanterol-in-the-management-of-moderate-and-severe-copd-in-china
#2
JOURNAL ARTICLE
Yuan Zhou, Shujing Duan, Lei Zhang, Fangchen Peng
OBJECTIVE: A study has analyzed the long-term cost-effectiveness of fluticasone furoate/umeclidinium bromide/vilanterol combination therapy (FF/UMEC/VI) versus umeclidinium bromide/vilanterol dual therapy (UMEC/VI) in the treatment of moderate or severe chronic obstructive pulmonary disease (COPD), providing evidence for decision-making in COPD treatment. METHODS: From the perspective of the whole society, a Markov model based on the severity of COPD was established, consisting of four states: moderate, severe, very severe, and death ...
April 13, 2024: Respiratory Medicine
https://read.qxmd.com/read/38582540/updated-cost-effectiveness-analysis-of-adebrelimab-plus-chemotherapy-for-extensive-stage-small-cell-lung-cancer-in-china
#3
JOURNAL ARTICLE
Yunchun Long, Hao Wang, Xianhai Xie, Junlin Li, Yuan Xu, Yujie Zhou
OBJECTIVE: The CAPSTONE-1 trial demonstrated that adebrelimab-based immunotherapy yielded a favourable survival benefit compared with chemotherapy for patients with extensive-stage small cell lung cancer (ES-SCLC). This study aims to evaluate the cost-effectiveness of this immunotherapy in the treatment of ES-SCLC from a healthcare system perspective in China. DESIGN: The TreeAge Pro software was used to establish a three-state partitioned survival model. Survival data came from the CAPSTONE-1 trial (NCT03711305), and only direct medical costs were included...
April 5, 2024: BMJ Open
https://read.qxmd.com/read/38554711/liverrisk-score-an-accurate-cost-effective-tool-to-predict-fibrosis-liver-related-and-diabetes-related-mortality-in-the-general-population
#4
JOURNAL ARTICLE
Shanghao Liu, Xiaohan Chen, Xuanwei Jiang, Xiaochun Yin, Ginenus Fekadu, Chuan Liu, Yan He, Huihui Chen, Wenjing Ni, Ruiying Wang, Qing-Lei Zeng, Yuping Chen, Ling Yang, Ruihua Shi, Sheng-Hong Ju, Jie Shen, Jingli Gao, Linhua Zhao, Wai-Kit Ming, Victor W Zhong, Gao-Jun Teng, Xiaolong Qi
BACKGROUND: Noninvasive and early assessment of liver fibrosis is of great significance and is challenging. We aimed to evaluate the predictive performance and cost-effectiveness of the LiverRisk score for liver fibrosis and liver-related and diabetes-related mortality in the general population. METHODS: The general population from the NHANES 2017-March 2020, NHANES 1999-2018, and UK Biobank 2006-2010 were included in the cross-sectional cohort (n = 3,770), along with the NHANES follow-up cohort (n = 25,317) and the UK Biobank follow-up cohort (n = 17,259)...
March 26, 2024: Med
https://read.qxmd.com/read/38514325/-cost-effectiveness-of-hcv-testing-strategies-for-hepatitis-c-elimination-in-general-population-in-china
#5
JOURNAL ARTICLE
P C Liu, D Xu, G W Ding, L Zhao, J J Yu, Z F Liu, J Li
Objective: To evaluate the cost-effectiveness of hepatitis C screening in general population in China, and find the age group in which hepatitis C screening can achieve the best cost-effectiveness. Methods: A decision-Markov model was constructed by using software TreeAge pro 2019 to simulate the outcomes of hepatitis C disease pregression of 100 000 persons aged 20-59 years. The cost-effectiveness of the strategies were evaluated from societal perspectives by using incremental cost-effectiveness ratio (ICER) and net monetary benefit (NMB)...
March 10, 2024: Zhonghua Liu Xing Bing Xue za Zhi, Zhonghua Liuxingbingxue Zazhi
https://read.qxmd.com/read/38502855/cost-effectiveness-analysis-of-endovascular-versus-open-repair-in-patients-with-abdominal-aortic-aneurysm-in-iran-a-cross-sectional-study
#6
JOURNAL ARTICLE
Shahin Nargesi, Ali Abutorabi, Yousef Mohamadi, Javad Salimi, Masih Tajdini, Vahid Alipour
OBJECTIVES: Abdominal aortic aneurysm is one of the most important cardiovascular diseases, especially in the elderly. People with this disease are at risk of rupture of the abdominal aorta and death. The present study was conducted with the aim of analyzing the cost effectiveness of endovascular repair compared to open surgery in abdominal aortic aneurysm patients in Iran. METHODS: A Markov chain model was developed based on the use of endovascular repair and open surgery...
March 19, 2024: International Journal of Surgery
https://read.qxmd.com/read/38480013/restoration-of-endodontically-treated-teeth-a-cost-effectiveness-analysis-of-an-endocrown-versus-a-complete-crown
#7
JOURNAL ARTICLE
Nighat Naved, Asif R Khowaja, Fahad Umer
STATEMENT OF PROBLEM: Endocrowns have been proposed as an alternative to post-and-core retained complete crowns for structurally compromised endodontically treated teeth. However, an analysis of their cost-effectiveness is lacking. PURPOSE: The purpose of this simulation study was to assess the cost-effectiveness of an endocrown versus a complete crown as a definitive restoration for structurally compromised endodontically treated teeth. MATERIAL AND METHODS: A Markov simulation model was constructed with endodontically treated permanent molar teeth using TreeAge Pro Healthcare (2023) as a starting point for an 18-year-old patient...
March 12, 2024: Journal of Prosthetic Dentistry
https://read.qxmd.com/read/38471764/the-feasibility-of-mechanical-thrombectomy-versus-medical-management-for-acute-stroke-with-a-large-ischemic-territory
#8
JOURNAL ARTICLE
Assala Aslan, Saad Abuzahra, Nimer Adeeb, Basel Musmar, Hamza A Salim, Sandeep Kandregula, Adam A Dmytriw, Christoph J Griessenauer, Luis De Alba, Octavio Arevalo, Jan Karl Burkhardt, Vitor M Pereira, Pascal Jabbour, Bharat Guthikonda, Hugo H Cuellar
BACKGROUND: Mechanical thrombectomy (MT) for acute ischemic stroke is generally avoided when the expected infarction is large (defined as an Alberta Stroke Program Early CT Score of <6). OBJECTIVE: To perform a meta-analysis of recent trials comparing MT with best medical management (BMM) for treatment of acute ischemic stroke with large infarction territory, and then to determine the cost-effectiveness associated with those treatments. METHODS: A meta-analysis of the RESCUE-Japan, SELECT2, and ANGEL-ASPECT trials was conducted using R Studio...
March 12, 2024: Journal of Neurointerventional Surgery
https://read.qxmd.com/read/38448887/peritoneal-dialysis-vs-hemodialysis-among-patients-with-end-stage-renal-disease-in-iran-which-is-more-cost-effective
#9
JOURNAL ARTICLE
Mahmood Yousefi, Satar Rezaei, Sakineh Hajebrahimi, Niloofar Falsafi, Fatemeh Keshvari-Shad
BACKGROUND: There is little economic evidence on different modalities among patients with end-stage renal disease (ESRD) in Iran. This study aimed to assess the cost-utility of peritoneal dialysis (PD) and hemodialysis (HD) among ESRD patients in Iran. METHODS: From the health system perspective and with a 10-year time horizon, we conducted a cost-utility analysis based on a Markov model to compare three strategies of PD and HD [the second scenario (30% PD, 70% HD), the third scenario (50% PD, 50% HD) and the fourth scenario (70% PD, 30% HD)] among ESRD patients with the current situation (PD, 3% vs...
March 6, 2024: BMC Nephrology
https://read.qxmd.com/read/38418999/irreversible-pulpitis-in-mature-permanent-teeth-a-cost-effectiveness-analysis-of-pulpotomy-versus-root-canal-treatment
#10
JOURNAL ARTICLE
Nighat Naved, Fahad Umer, Asif R Khowaja
INTRODUCTION: Evidence-based dentistry suggests pulpotomy as a potential alternative to root canal treatment in mature permanent teeth with irreversible pulpitis. However, the evidence surrounding the cost-valuation and cost-efficacy of this treatment modality is not yet established. In this context, we adopted an economic modeling approach to assess the cost-effectiveness of pulpotomy versus root canal treatment, as this could aid in effective clinical decision-making. METHODS: A Markov model was constructed following a mature permanent tooth with irreversible pulpitis in an 18-year-old patient over a lifetime using TreeAge Pro Healthcare 2022...
February 28, 2024: BMC Oral Health
https://read.qxmd.com/read/38340488/which-localizing-strategy-is-the-most-cost-effective-in-reoperative-primary-hyperparathyroidism
#11
JOURNAL ARTICLE
Victor Gazivoda, Katherine M Prioli, Albert C Li, Laura Pizzi, Amanda M Laird, Toni Beninato
INTRODUCTION: 2%-10% of patients with primary hyperparathyroidism (PHPT) who undergo parathyroidectomy develop persistent/recurrent disease. The aim of this study was to determine which preoperative localization method is most cost-effective in reoperative PHPT. METHODS: Clinical decision analytic models comparing cost-effectiveness of localizing studies in reoperative PHPT were constructed using TreeAge Pro. Cost and probability assumptions were varied via Probabilistic Sensitivity Analysis (PSA) to test the robustness of the base case models...
April 2024: Journal of Surgical Research
https://read.qxmd.com/read/38207326/urethral-bulking-with-polyacrylamide-hydrogel-compared-with-other-treatments-for-stress-urinary-incontinence-a-cost-effectiveness-analysis
#12
JOURNAL ARTICLE
Olivia H Chang, Jonathan P Shepherd, Lauren A Cadish, Shannon L Wallace, Brad St Martin, Eric R Sokol
Our objective was to perform a cost-effectiveness analysis comparing polyacrylamide hydrogel urethral bulking with other surgical and nonsurgical treatments for stress urinary incontinence (SUI). We created a cost-effectiveness analysis using TreeAge Pro, modeling eight SUI treatments. Treatment with midurethral sling (MUS) had the highest effectiveness (1.86 quality-adjusted life-years [QALYs]), followed by polyacrylamide hydrogel (1.82 QALYs), with a difference (Δ 0.02/year) less than the minimally important difference for utilities of 0...
March 1, 2024: Obstetrics and Gynecology
https://read.qxmd.com/read/38059348/cost-effectiveness-of-btk-inhibitors-vs-bendamustine-and-rituximab-in-chronic-lymphocytic-leukemia-patients
#13
JOURNAL ARTICLE
Jing Nie, Huina Wu, Qian Wu, Qi Liu, Lihui Liu, Jiyong Wu
Background: We aimed to compare the cost-effectiveness of bruton tyrosine kinase inhibors (BTKis) versus bendamustine-rituximab (R-bendamustine) as a first-line treatment for Chinese patients with relapsed or refractory chronic lymphocytic leukemia. Methods: A partitioned survival model was constructed using TreeAge Pro 2022 software and transition probabilities were estimated from the reported survival probabilities using parametric survival modeling. One-way analysis and probabilistic sensitivity analysis were performed to explore the uncertainty of the modeling results...
December 7, 2023: Future Oncology
https://read.qxmd.com/read/38029373/a-markov-analysis-of-azacitidine-and-venetoclax-versus-induction-chemotherapy-for-medically-fit-patients-with-aml
#14
JOURNAL ARTICLE
Mithunan Ravindran, Lee Mozessohn, Matthew C Cheung, Rena J Buckstein, Jennifer Teichman
While induction chemotherapy (IC) is the standard of care in medically-fit patients with newly diagnosed acute myeloid leukemia (AML), limited retrospective data indicate that adverse risk patients may benefit from azacitidine and venetoclax (aza-ven). Our goal was to perform a Markov decision analysis to determine whether IC or aza-ven is the optimal induction regimen in this population. Using the TreeAge software, Markov models were created for adverse risk and intermediate risk cohorts. A systematic review of the literature informed the transition probabilities and utilities included in the analyses...
November 29, 2023: Blood Advances
https://read.qxmd.com/read/37971984/cost-effectiveness-analysis-of-artificial-intelligence-based-diabetic-retinopathy-screening-in-rural-china-based-on-the-markov-model
#15
JOURNAL ARTICLE
Huilin Li, Guanyan Li, Na Li, Changyan Liu, Ziyou Yuan, Qingyue Gao, Shaofeng Hao, Shengfu Fan, Jianzhou Yang
This study assessed the cost-effectiveness of different diabetic retinopathy (DR) screening strategies in rural regions in China by using a Markov model to make health economic evaluations. In this study, we determined the structure of a Markov model according to the research objectives, which required parameters collected through field investigation and literature retrieval. After perfecting the model with parameters and assumptions, we developed a Markov decision analytic model according to the natural history of DR in TreeAge Pro 2011...
2023: PloS One
https://read.qxmd.com/read/37943359/cost-utility-analysis-of-palbociclib%C3%A2-%C3%A2-letrozole-and-ribociclib%C3%A2-%C3%A2-letrozole-versus-letrozole-monotherapy-in-the-first-line-treatment-of-metastatic-breast-cancer-in-iran-using-partitioned-survival-model
#16
JOURNAL ARTICLE
Ali Darvishi, Rajabali Daroudi, Ali Akbar Fazaeli
BACKGROUND: Palbociclib and Ribociclib are cyclin-dependent kinase 4/6 oral molecular inhibitors that have the potential to improve overall survival (OS), progression-free survival (PFS), and quality of life in patients with metastatic breast cancer (MBC). The objective of this study was to analyze the cost-utility of Palbociclib and Ribociclib in comparison with Letrozole monotherapy as the first-line treatment for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) MBC patients in Iran...
November 9, 2023: Health Economics Review
https://read.qxmd.com/read/37853803/optimal-timing-of-delivery-for-growth-restricted-fetuses-with-gastroschisis-a-decision-analysis
#17
JOURNAL ARTICLE
Claire H Packer, Rachel A Pilliod, Aaron B Caughey, Teresa N Sparks
OBJECTIVE: Our objective was to determine the optimal timing of delivery of growth restricted fetuses with gastroschisis in the setting of normal umbilical artery (UA) Dopplers. METHODS: We designed a decision analytic model using TreeAge software for a hypothetical cohort of 2000 fetuses with isolated gastroschisis, fetal growth restriction (FGR), and normal UA Dopplers across 34-39 weeks of gestation. This model accounted for costs and quality adjusted life years (QALYs) for the pregnant individual and the neonate...
November 2023: Prenatal Diagnosis
https://read.qxmd.com/read/37845696/first-line-nivolumab-plus-ipilimumab-for-unresectable-mpm-in-china-a-cost-effectiveness-analysis
#18
JOURNAL ARTICLE
Liu Yang, Xiaobing Song, Wanxian Zeng, Zhiwei Zheng, Wenqiang Lin
BACKGROUND: The regimen of nivolumab plus ipilimumab (NI) has been recommended by the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology-Malignant Pleural Mesothelioma (Version 1.2022) and Chinese Guidelines for the Clinical Diagnosis and Treatment of Malignant Pleural Mesothelioma (2021 edition) as the first-line treatment for Malignant Pleural Mesothelioma (MPM). But whether immunotherapy has a financial advantage over conventional chemotherapy (pemetrexed plus cisplatin/carboplatin, C) is uncertain...
October 16, 2023: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/37839058/cost-effectiveness-analysis-of-different-screening-strategies-for-helicobacter-pylori-infection-in-iran-a-model-based-evaluation
#19
JOURNAL ARTICLE
Mahmood Yousefi, Satar Rezaei, Manouchehr Khoshbaten, Maryam Sarmasti
BACKGROUND: The World Health Organization recommends assessing screening for helicobacter pylori infection to lower gastric cancer (GC) rates. Therefore, we carried out a study to evaluate the cost-effectiveness of different H. pylori screening approaches in Iran. MATERIALS AND METHODS: We used a Markov model with a 50-year time horizon and health system perspective to compare four H. pylori screening strategies (endoscopy, serology, urea breath test [UBT], stool antigen test [SAT]) to no screening in the population aged 20 years and older in Iran...
October 15, 2023: Helicobacter
https://read.qxmd.com/read/37667669/vaginal-hysteropexy-compared-with-vaginal-hysterectomy-with-apical-suspension-for-the-treatment-of-pelvic-organ-prolapse-a-5-year-cost-effectiveness-markov-model
#20
JOURNAL ARTICLE
Shannon L Wallace, Raveen Syan, Kyueun Lee, Eric R Sokol
OBJECTIVE: Our objective was to perform a 5-year cost-effectiveness analysis of transvaginal hysteropexy (HP) via sacrospinous ligament fixation (SS) or uterosacral ligament suspension (US) versus vaginal hysterectomy (VH) with apical suspension via sacrospinous ligament fixation (SS) or uterosacral ligament suspension (US) for the treatment of uterine prolapse. DESIGN: A decision analytic model assessed the cost-effectiveness of the surgical intervention over a 5-year horizon...
September 5, 2023: BJOG: An International Journal of Obstetrics and Gynaecology
keyword
keyword
24878
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.